189 related articles for article (PubMed ID: 8761588)
21. Effect of a single dose of diethylcarbamazine, albendazole or both on the clearance of Wuchereria bancrofti microfilariae and antigenaemia among microfilaria carriers: a randomized trial.
Hoti SL; Pani SP; Vanamail P; Athisaya Mary K; Das LK; Das PK
Natl Med J India; 2010; 23(2):72-6. PubMed ID: 20925201
[TBL] [Abstract][Full Text] [Related]
22. Clearance of Wuchereria bancrofti antigen after treatment with diethylcarbamazine or ivermectin.
Eberhard ML; Hightower AW; Addiss DG; Lammie PJ
Am J Trop Med Hyg; 1997 Oct; 57(4):483-6. PubMed ID: 9347968
[TBL] [Abstract][Full Text] [Related]
23. Short-term effects of treatment with 300 mg oral-dose diethylcarbamazine on nocturnally periodic Wuchereria bancrofti microfilaremia and antigenemia.
Siriaut C; Bhumiratana A; Koyadun S; Anurat K; Satitvipawee P
Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):832-40. PubMed ID: 16295533
[TBL] [Abstract][Full Text] [Related]
24. Children and adolescents infected with Wuchereria bancrofti in Greater Recife, Brazil: a randomized, year-long clinical trial of single treatments with diethylcarbamazine or diethylcarbamazine-albendazole.
Rizzo JA; Belo C; Lins R; Dreyer G
Ann Trop Med Parasitol; 2007 Jul; 101(5):423-33. PubMed ID: 17550648
[TBL] [Abstract][Full Text] [Related]
25. Microfilariae of Wuchereria bancrofti in urine: an uncommon finding.
Verma R; Vij M
Diagn Cytopathol; 2011 Nov; 39(11):847-8. PubMed ID: 21994197
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of effectiveness of diethylcarbamazine/albendazole combination in reduction of Wuchereria bancrofti infection using multiple infection parameters.
Wamae CN; Njenga SM; Ngugi BM; Mbui J; Njaanake HK
Acta Trop; 2011 Sep; 120 Suppl 1():S33-8. PubMed ID: 20933491
[TBL] [Abstract][Full Text] [Related]
27. Surveillance of imported bancroftian filariasis after two-year multiple-dose diethylcarbamazine treatment.
Koyadun S; Bhumiratana A
Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):822-31. PubMed ID: 16295532
[TBL] [Abstract][Full Text] [Related]
28. Lymphatic pathology in Wuchereria bancrofti microfilaraemic infections.
Dissanayake S; Watawana L; Piessens WF
Trans R Soc Trop Med Hyg; 1995; 89(5):517-21. PubMed ID: 8560529
[TBL] [Abstract][Full Text] [Related]
29. Advantages of an annual single dose of ivermectin 400 micrograms/kg plus diethylcarbamazine for community treatment of bancroftian filariasis.
Moulia-Pelat JP; Nguyen LN; Hascoët H; Luquiaud P; Nicolas L
Trans R Soc Trop Med Hyg; 1995; 89(6):682-5. PubMed ID: 8594696
[TBL] [Abstract][Full Text] [Related]
30. Pathogenesis of filarial hydrocele: risk associated with intrascrotal nodules caused by death of adult Wuchereria bancrofti.
Noroes J; Addiss D; Cedenho A; Figueredo-Silva J; Lima G; Dreyer G
Trans R Soc Trop Med Hyg; 2003; 97(5):561-6. PubMed ID: 15307427
[TBL] [Abstract][Full Text] [Related]
31. Mass DEC chemotherapy for control of bancroftian filariasis: comparative efficacy of four strategies two years after start of treatment.
Meyrowitsch DW; Simonsen PE; Makunde WH
Trans R Soc Trop Med Hyg; 1996; 90(4):423-8. PubMed ID: 8882196
[TBL] [Abstract][Full Text] [Related]
32. Mass diethylcarbamazine chemotherapy for control of bancroftian filariasis through community participation: comparative efficacy of a low monthly dose and medicated salt.
Meyrowitsch DW; Simonsen PE; Makunde WH
Trans R Soc Trop Med Hyg; 1996; 90(1):74-9. PubMed ID: 8730318
[TBL] [Abstract][Full Text] [Related]
33. Tolerability and efficacy of a three-age class dosage schedule of Diethylcarbamazine citrate (DEC) in the treatment of microfilaria carriers of Wuchereria bancrofti and its implications in mass drug administration (MDA) strategy for elimination of lymphatic filariasis (LF).
Pani SP; Das LK; Vanamail P
J Commun Dis; 2005 Mar; 37(1):12-7. PubMed ID: 16637395
[TBL] [Abstract][Full Text] [Related]
34. Diethylcarbamazine: effect on lysosomal enzymes and acetylcholine in Wuchereria bancrofti infection.
Bhattacharya C; Singh RN; Misra S; Rathaur S
Trop Med Int Health; 1997 Jul; 2(7):686-90. PubMed ID: 9270736
[TBL] [Abstract][Full Text] [Related]
35. Wuchereria bancrofti antigenemia clearance among Myanmar migrants after biannual mass treatments with diethylcarbamazine, 300 mg oral-dose FILADEC tablet, in Southern Thailand.
Koyadun S; Bhumiratana A; Prikchu P
Southeast Asian J Trop Med Public Health; 2003 Dec; 34(4):758-67. PubMed ID: 15115084
[TBL] [Abstract][Full Text] [Related]
36. The influence of the mass administration of diethylcarbamazine, alone or with albendazole, on the prevalence of filarial antigenaemia.
Rajendran R; Sunish IP; Mani TR; Munirathinam A; Abdullah SM; Augustin DJ; Satyanarayana K
Ann Trop Med Parasitol; 2002 Sep; 96(6):595-602. PubMed ID: 12396322
[TBL] [Abstract][Full Text] [Related]
37. Bancroftian filariasis in residents of Oman.
Scrimgeour EM; Idris MA; Al-Riyami BM; El-Shafie OT; Johnston WJ; Woodhouse NJ; Mohsen N
Acta Trop; 2001 Jun; 79(3):241-4. PubMed ID: 11412808
[No Abstract] [Full Text] [Related]
38. Effect of different DEC schedules on microfilaraemia & filarial antibody levels in bancroftian filariasis.
Malhotra A; Ghirnikar SN; Harinath BC
Indian J Med Res; 1983 Sep; 78():343-8. PubMed ID: 6370849
[No Abstract] [Full Text] [Related]
39. Reduction of Wuchereria bancrofti adult worm circulating antigen after annual treatments of diethylcarbamazine combined with ivermectin in French Polynesia.
Nicolas L; Plichart C; Nguyen LN; Moulia-Pelat JP
J Infect Dis; 1997 Feb; 175(2):489-92. PubMed ID: 9203681
[TBL] [Abstract][Full Text] [Related]
40. Mass diethylcarbamazine chemotherapy for control of bancroftian filariasis: comparative efficacy of standard treatment and two semi-annual single-dose treatments.
Meyrowitsch DW; Simonsen PE; Makunde WH
Trans R Soc Trop Med Hyg; 1996; 90(1):69-73. PubMed ID: 8730317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
